D-0296-2022 Class II Ongoing

Recalled by Teligent Pharma, Inc. — Buena, NJ

FDA drug recall D-0296-2022 was initiated by Teligent Pharma, Inc. on Nov 30, 2021 and is designated Class II. Reason for recall: Superpotent Drug: Minimally superpotent The recall status is ongoing. Affected quantity: 7,176 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 5, 2022
Initiation Date
Nov 30, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7,176 bottles

Product description

Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only, Manufactured by Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-997-64

Reason for recall

Superpotent Drug: Minimally superpotent

Distribution pattern

Distributed to a wholesaler in CO who further distributed Nationwide in the USA

Code information

Lot #: 15594, Exp Date 05/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0296-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0296-2022. Report a data issue: hello@regdatalab.com.